According to PAVmed 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.20238. At the end of 2022 the company had a P/E ratio of -0.4800.
Year | P/E ratio | Change |
---|---|---|
2022 | -0.4800 | -87.32% |
2021 | -3.78 | 30.32% |
2020 | -2.90 | 33.11% |
2019 | -2.18 | 97.32% |
2018 | -1.11 | -62.74% |
2017 | -2.97 | -81.84% |
2016 | -16.3 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | -2.20 | 0.00% | ๐บ๐ธ USA |
Philips PHG | -29.4 | 1,234.84% | ๐ณ๐ฑ Netherlands |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.